Extended regorafenib treatment can be linked with mitochondrial damage leading to cardiotoxicity.

Boran, TAkyildiz, AYŞENURJannuzzi, ATAlpertunga, B2020-11-212020-11-212020-11-06Boran T., Akyildiz A., Jannuzzi A., Alpertunga B., -Extended regorafenib treatment can be linked with mitochondrial damage leading to cardiotoxicity.-, Toxicology letters, 2020http://hdl.handle.net/20.500.12645/27394Extended regorafenib treatment can be linked with mitochondrial damage leading to cardiotoxicity.Article10.1016/j.toxlet.2020.11.00333166663